http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102802623-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75045561417abca19482cc4a63370331
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D271-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
filingDate 2010-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ae021026ad31eed987ab4d44865a88f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fe37e58b95baa838fdde735e188ce79
publicationDate 2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102802623-A
titleOfInvention Compounds, compositions and methods containing 1,3,4-oxadiazole derivatives
abstract The present invention relates to compositions and methods for treating a disease in an animal responsive to inhibition of a functional cystic fibrosis transmembrane conductance regulator (CFTR) polypeptide, said method comprising administering an effective amount of Compounds of the present invention (including those listed in Tables 1 to 2 and those encompassed by Formulas I to IV) or compositions containing these compounds are administered to a mammal in need thereof, thereby treating the disease. In particular, the invention relates to methods of treating diarrhea and polycystic kidney disease.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111423394-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107922362-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111320617-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107922362-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104974106-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104974106-B
priorityDate 2009-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005130970-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006100591-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03099821-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008269206-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467932065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466730711

Total number of triples: 31.